查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1782021

微創活體組織切片技術市場，按產品提供、按技術、按循環生物標記、按應用、按最終用戶、按國家和地區分類 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率及預測

Minimally Invasive Biopsy Techniques Market, By Product Offered, By Technique, By Circulating Biomarker, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 393 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年微創切片技術市場規模價值為 131.4612 億美元，2025 年至 2032 年的複合年成長率為 10.5%。

微創切片技術市場-市場動態

全球癌症盛行率的不斷上升以及精準診斷日益成長的重要性預計將推動市場成長。

隨著全球癌症發生率持續上升，迫切需要早期、精準且微創的診斷方法。與傳統手術方法相比，包括細針穿刺、芯針活體組織切片和液體活體組織切片在內的微創活體組織切片技術可縮短患者恢復時間，減輕患者不適，並降低併發症發生率。世界衛生組織估計，到2050年，新增癌症病例預計將達到3,500萬例，比2022年記錄的2,000萬例增加77%。儘管如此，對腫瘤學研究、個人化醫療和醫療創新的投入不斷增加，或將為市場擴張帶來機會。此外，先進活體組織切片系統的高昂成本可能會阻礙市場成長。

微創活體組織切片技術市場—關鍵見解

根據我們的研究分析師的分析，預計全球市場在預測期內（2025-2032 年）的年複合成長率約為 10.5%。

根據產品供應細分，預計套件和耗材將在 2024 年佔據最大市場佔有率

根據技術細分，液體活體組織切片是 2024 年的領先技術

根據循環生物標記細分，遊離 DNA（cfDNA）是 2024 年領先的循環生物標記

根據應用細分，臨床是 2024 年領先的應用

根據最終用戶細分，醫院和診所是 2024 年的主要最終用戶

從地區來看，北美是 2024 年最大的收入來源

微創活體組織切片技術市場細分分析：

全球微創活體組織切片技術市場根據產品供應、技術、循環生物標記、應用、最終用戶和地區進行細分。

根據產品類型，市場可分為三個部分：檢測試劑、試劑盒及耗材以及儀器。試劑盒及耗材因其使用頻率高、一次性使用以及在確保診斷程序無菌和準確方面發揮重要作用，在市場中佔據主導地位。此類產品包括活體組織切片針、鑷子、注射器、試劑和樣本採集容器，所有這些對於各種活體組織切片方法都至關重要，包括細針抽吸、芯針活體組織切片和真空輔助活體組織切片。醫院、診斷實驗室和門診對這些產品的持續需求顯著提升了其龐大的市場佔有率。

根據技術，市場可分為四大細分領域：液體切片、光學切片、刷檢、色素病變檢測及其他。液體活體組織切片正處於市場擴張的前沿，因為它能夠透過簡單的抽血來識別癌症相關的生物標記，從而提供比傳統組織活體組織切片更安全、更快捷、更以患者為中心的替代方案。它有助於即時監測病情進展、早期癌症檢測和評估治療效果，且無需侵入性操作。精準醫療的日益普及以及對早期癌症診斷需求的不斷成長，推動了液體活體組織切片在各種臨床環境中的快速發展和普及。

根據循環生物標記物，市場可分為四個細分領域：循環腫瘤細胞 (CTC)、遊離DNA (cfDNA)、循環腫瘤DNA (ctDNA)、細胞外囊泡及其他。遊離DNA (cfDNA) 是市場成長的主要驅動力。在液體活體組織切片領域，遊離DNA (cfDNA) 因其在非侵入性癌症診斷和監測中的重要作用而處於市場擴張的前沿。透過分析腫瘤釋放到血液中的DNA片段，cfDNA有助於識別基因突變、腫瘤負荷和治療抗藥性。它無需手術干預即可即時洞察腫瘤動態，已成為精準腫瘤學的基礎要素。

根據應用，市場可分為兩類：臨床和治療。臨床是市場成長的主要驅動力。臨床應用是微創活體組織切片技術市場擴張的前沿，這得益於這些技術在標準診斷和疾病監測中的日益普及。醫院、診斷實驗室和專科診所正在逐步採用液體活體組織切片、細針穿刺和影像引導活體組織切片等微創技術，以實現早期發現和個人化治療計劃，尤其是在腫瘤學領域。

根據最終用戶，市場可分為三類：醫院和診所、學術和研究機構以及門診護理中心。醫院和診所憑藉其龐大的患者數量、先進的診斷設施以及專業醫護人員的專業知識，在微創活體組織切片技術領域的最終用戶中佔據市場成長的前沿。這些場所是疾病檢測的主要場所，尤其是在腫瘤科，通常進行細針抽吸、芯針活體組織切片和液體活體組織切片等操作。學術和研究機構也發揮著至關重要的作用，致力於創新活體組織切片方法的進步和生物標記的發現。相較之下，由於人們越來越傾向於門診、經濟高效且恢復時間更快的微創手術，門診護理中心的採用率正在上升。

微創活體組織切片技術市場-地理洞察

北美引領市場成長，主要得益於液體活體組織切片的日益普及。癌症發生率的上升，以及對早期診斷和精準診斷的高度重視，加速了液體活體組織切片在臨床實踐中的應用。此外，知名生物技術公司、先進的醫療基礎設施以及支援性監管框架的存在，進一步推動了市場成長。美國人口超過3.3億，擁有全球最複雜的醫療保健體系之一，其特點是醫療服務提供者、付款人和接受治療的患者之間相互關聯。由於成像和導航技術的進步，歐洲成為市場成長第二大地區。

微創切片技術市場-競爭格局：

微創活體組織切片技術市場的競爭環境以眾多知名醫療器材製造商、診斷公司和新興生物技術新創公司的參與為特徵。領先的公司正在開發先進的影像引導、機器人輔助和人工智慧整合的活體組織切片解決方案，旨在提高準確性並降低手術風險。各機構正在投資非侵入性液體活體組織切片技術，尤其是那些專注於循環腫瘤DNA (ctDNA) 和遊離DNA (cfDNA) 的技術，以實現即時癌症監測。此外，各公司正在拓展其在亞太和拉丁美洲地區的業務，以利用對微創診斷方法日益成長的需求。

最新動態：

2025年1月22日，位於厄本代爾和克萊夫的愛荷華州GRACE乳房影像與醫療水療中心（GRACE Breast Imaging & Medical Spa）取得了重大里程碑，成為美國首家安裝創新Mammomat B.brilliant的醫療機構。這標誌著西門子醫療十多年來首次對乳房X光檢查平台進行全面重新設計。 Mammomat B.brilliant融合了先進的3D影像擷取和影像重建技術，並具備全視野數位乳房X光檢查功能，包括2D乳房成像、乳房活體組織切片和鈦增強乳房X光檢查。

目錄

第1章：微創活體組織切片技術市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 微創活體組織切片技術市場片段（按產品提供）
    • 微創活體組織切片技術市場片段（按技術）
    • 循環生物製造商的微創活體組織切片技術市場摘要
    • 微創活體組織切片技術市場片段（按應用）
    • 微創活體組織切片技術市場片段（按最終用戶）
    • 各國微創切片技術市場概況
    • 微創活體組織切片技術市場（按地區）
  • 競爭洞察

第3章：微創切片技術關鍵市場趨勢

  • 微創活體組織切片技術市場促進因素
    • 市場促進因素的影響分析
  • 微創切片技術市場限制
    • 市場限制的影響分析
  • 微創切片技術市場機遇
  • 微創活體組織切片技術市場未來趨勢

第4章：微創切片技術產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：微創切片技術市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：微創切片技術市場格局

  • 2024年微創切片技術市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：微創切片技術市場－依產品分類

  • 概述
    • 按產品細分市場佔有率分析
    • 測試
    • 套件和耗材
    • 儀器

第 8 章：微創活體組織切片技術市場 - 按技術

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 液體活體組織切片
    • 光學活體組織切片
    • 刷檢
    • 色素病灶檢測
    • 其他

第9章：微創切片技術市場－循環生物製造商

  • 概述
    • 按循環生物製造商分類的細分市場佔有率分析
    • 循環腫瘤細胞（CTC）
    • 遊離DNA（cfDNA）
    • 循環腫瘤DNA（ctDNA）
    • 細胞外囊泡
    • 其他

第 10 章：微創活體組織切片技術市場 - 按應用

  • 概述
    • 按應用細分市場佔有率分析
    • 臨床
      • 治療監測
      • 預後和復發監測
      • 治療選擇
      • 其他
    • 治療
      • 肺癌
      • 乳癌
      • 攝護腺癌
      • 大腸直腸癌
      • 其他

第 11 章：微創活體組織切片技術市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院和診所
    • 學術及研究機構
    • 門診護理中心

第 12 章：微創活體組織切片技術市場 - 按地區

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美微創活體組織切片技術主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品提供）
    • 北美市場規模和預測（按技術）
    • 北美市場規模及預測（按循環生物製造商）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲微創活體組織切片技術主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按產品提供）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模及預測（按循環生物製造商）
    • 歐洲市場規模和預測，按應用
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區微創切片技術主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品提供）
    • 亞太地區市場規模及預測（依技術）
    • 亞太地區市場規模及預測（按循環生物製造商）
    • 亞太地區市場規模及預測（按應用）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲微創活體組織切片技術主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（依產品提供）
    • 拉丁美洲市場規模及預測（按技術）
    • 拉丁美洲市場規模及預測（按循環生物製造商）
    • 拉丁美洲市場規模及預測（按應用）
    • LATAM 規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲微創活體組織切片技術主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 中東和非洲市場規模及預測（按產品提供）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按循環生物製造商）
    • 中東和非洲市場規模和預測（按應用）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 13 章：關鍵供應商分析-微創活體組織切片技術產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Becton, Dickinson and Company (BD)
    • Danaher Corporation (Leica Biosystems)
    • Hologic, Inc.
    • Boston Scientific Corporation
    • Medtronic plc
    • Siemens Healthineers
    • GE HealthCare
    • Philips Healthcare
    • Argon Medical Devices
    • Cook Medical
    • Fujifilm Holdings Corporation
    • Olympus Corporation
    • R. Bard (now part of BD)
    • Biocept, Inc.
    • Guardant Health
    • Qiagen NV
    • Exact Sciences Corporation
    • Bio-Rad Laboratories
    • Menarini Silicon Biosystems
    • NeoGenomics Laboratories
    • Others

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5422

REPORT HIGHLIGHT

Minimally Invasive Biopsy Techniques Market size was valued at US$ 13,146.12 Million in 2024, expanding at a CAGR of 10.5% from 2025 to 2032.

Minimally invasive biopsy techniques refer to procedures that obtain tissue samples for diagnostic purposes through smaller incisions and with less damage to surrounding tissue than traditional surgical biopsies. These methods present benefits such as diminished scarring, quicker recovery times, and a lower likelihood of complications. Frequently utilized techniques include fine-needle aspiration (FNA), core needle biopsy (CNB), and vacuum-assisted biopsy (VAB), which are often performed with the assistance of imaging technologies such as ultrasound, MRI, or mammography. Overall, minimally invasive biopsy techniques represent a significant advancement in tissue sampling, delivering precise diagnoses while minimizing the burden on patients.

Minimally Invasive Biopsy Techniques Market- Market Dynamics

The increasing global prevalence of cancer, along with the growing significance of precision diagnostics, is anticipated to propel market growth.

As the incidence of cancer continues to rise globally, there is an urgent requirement for early, precise, and less invasive diagnostic methods. Minimally invasive biopsy techniques, including fine-needle aspiration, core needle biopsy, and liquid biopsy, provide quicker recovery times, decreased patient discomfort, and lower rates of complications when compared to conventional surgical approaches. The World Health Organization estimates that the number of new cancer cases is expected to reach 35 million by 2050, which signifies a 77% increase from the 20 million cases documented in 2022. Nevertheless, increasing investments in oncology research, personalized medicine, and healthcare innovation may present opportunities for market expansion. Furthermore, the high costs associated with advanced biopsy systems could hinder market growth.

Minimally Invasive Biopsy Techniques Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.5% over the forecast period (2025-2032)

Based on Product Offered segmentation, Kits & Consumables were predicted to show the maximum market share in the year 2024

Based on Technique segmentation, Liquid Biopsy was the leading Technique in 2024

Based on Circulating Biomarker segmentation, cell-free DNA (cfDNA) was the leading Circulating Biomarker in 2024

Based on Application segmentation, Clinical was the leading Application in 2024

Based on end-user segmentation, Hospitals and clinics were the leading end users in 2024

Based on region, North America was the leading revenue generator in 2024

Minimally Invasive Biopsy Techniques Market- Segmentation Analysis:

The Global Minimally Invasive Biopsy Techniques Market is segmented based on Product Offered, Technique, Circulating Biomarker, Application, End User, and Region.

The market is divided into three segments according to the Products Offered: Tests, Kits & Consumables, and Instruments. Kits & Consumables occupy a leading role in the market, attributed to their frequent usage, disposability, and essential function in ensuring sterile and accurate diagnostic procedures. This category encompasses biopsy needles, forceps, syringes, reagents, and sample collection containers, all of which are vital for various biopsy methods, including fine-needle aspiration, core needle biopsy, and vacuum-assisted biopsy. The ongoing demand for these products in hospitals, diagnostic laboratories, and outpatient settings significantly boosts their substantial market share.

The market is categorized into four segments based on Technique: Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, and Others. Liquid Biopsy is at the forefront of market expansion, owing to its capability to identify cancer-related biomarkers through a straightforward blood draw, providing a safer, quicker, and more patient-centric alternative to conventional tissue biopsies. It facilitates real-time monitoring of disease progression, early cancer detection, and evaluation of treatment responses without requiring invasive procedures. The growing adoption of precision medicine and the increasing demand for early cancer diagnostics are propelling the swift growth and acceptance of liquid biopsy in various clinical environments.

The market is categorized into four segments based on circulating Biomarkers: Circulating Tumor Cells (CTCs), Cell-Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, and Others. Cell-Free DNA (cfDNA) is the primary driver of market growth. Within the liquid biopsy sector, cell-free DNA (cfDNA) is at the forefront of market expansion due to its essential function in non-invasive cancer diagnostics and monitoring. By analyzing fragments of DNA released by tumors into the bloodstream, cfDNA facilitates the identification of genetic mutations, tumor burden, and treatment resistance. Its capacity to deliver real-time insights into tumor dynamics without requiring surgical interventions has established it as a fundamental element in precision oncology.

The market is segmented into two categories according to Application: Clinical and Therapeutic. Clinical is the primary driver of market growth. Clinical applications are at the forefront of market expansion in minimally invasive biopsy techniques, propelled by the rising adoption of these procedures in standard diagnostics and disease monitoring. Hospitals, diagnostic laboratories, and specialty clinics are progressively employing minimally invasive techniques such as liquid biopsy, fine-needle aspiration, and image-guided biopsies for early detection and tailored treatment planning, especially in the field of oncology.

The market is segmented into three categories based on End-User: Hospitals & Clinics, Academic & Research Institutions, and Ambulatory Care Centers. Hospitals and clinics are at the forefront of market growth among end users in the minimally invasive biopsy techniques sector, attributed to the high patient volume, the presence of advanced diagnostic facilities, and the expertise of medical professionals. These environments serve as the primary point of care for disease detection, particularly in oncology, where procedures such as fine-needle aspiration, core needle biopsy, and liquid biopsy are commonly conducted. Academic and research institutions also play a vital role, concentrating on the advancement of innovative biopsy methods and the discovery of biomarkers. In contrast, ambulatory care centers are witnessing an increase in adoption due to the growing preference for outpatient, cost-effective, and minimally invasive procedures that offer faster recovery times.

Minimally Invasive Biopsy Techniques Market- Geographical Insights

North America leads in market growth, primarily due to the increasing adoption of liquid biopsy. The rising incidence of cancer, along with a strong focus on early and accurate diagnosis, has expedited the incorporation of liquid biopsy into clinical practices. Furthermore, the presence of prominent biotechnology firms, sophisticated healthcare infrastructure, and supportive regulatory frameworks has further propelled market growth. The United States (US), with a population exceeding 330 million, benefits from one of the most intricate healthcare systems globally, characterized by the interconnected relationships among providers, payers, and patients receiving care. Europe ranks as the second largest region for market growth, attributed to advancements in imaging and navigation technologies.

Minimally Invasive Biopsy Techniques Market- Competitive Landscape:

The competitive environment of the Minimally Invasive Biopsy Techniques Market is characterized by the participation of various established medical device manufacturers, diagnostic firms, and emerging biotech startups. Leading companies are developing advanced imaging-guided, robotic-assisted, and AI-integrated biopsy solutions designed to enhance accuracy and reduce procedural risks. Organizations are investing in non-invasive liquid biopsy technologies, especially those focusing on circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA), to enable real-time cancer monitoring. Furthermore, companies are broadening their operations in the Asia-Pacific and Latin America regions to take advantage of the growing demand for less invasive diagnostic approaches.

Recent Developments:

On January 22, 2025, GRACE Breast Imaging & Medical Spa of Iowa, located in Urbandale and Clive, achieved a significant milestone by becoming the first healthcare facility in the United States to install the innovative Mammomat B.brilliant. This marks the first complete redesign of a mammography platform by Siemens Healthineers in over ten years. The Mammomat B.brilliant incorporates advanced 3D image acquisition and image reconstruction technology, along with capabilities for full-field digital mammography, which includes two-dimensional breast imaging, breast biopsy, and titanium contrast-enhanced mammography.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Becton, Dickinson and Company (BD)
  • Danaher Corporation (Leica Biosystems)
  • Hologic, Inc.
  • Boston Scientific Corporation
  • Medtronic plc
  • Siemens Healthineers
  • GE HealthCare
  • Philips Healthcare
  • Argon Medical Devices
  • Cook Medical
  • Fujifilm Holdings Corporation
  • Olympus Corporation
  • R. Bard (now part of BD)
  • Biocept, Inc.
  • Guardant Health
  • Qiagen N.V.
  • Exact Sciences Corporation
  • Bio-Rad Laboratories
  • Menarini Silicon Biosystems
  • NeoGenomics Laboratories
  • Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY PRODUCT OFFERED- MARKET ANALYSIS, 2019 - 2032

  • Tests
  • Kits & Consumables
  • Instruments

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

  • Liquid Biopsy
  • Optical Biopsy
  • Brush Biopsy
  • Pigmented Lesion Assays
  • Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY CIRCULATING BIOMAKER- MARKET ANALYSIS, 2019 - 2032

  • Circulating Tumor Cells (CTCs)
  • Cell Free DNA (cfDNA)
  • Circulating Tumor DNA (ctDNA)
  • Extracellular Vesicles
  • Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Clinical
  • Treatment Monitoring
  • Prognosis & Recurrence Monitoring
  • Treatment Selection
  • Others
  • Therapeutic
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Ambulatory Care Centers

GLOBAL MINIMALLY INVASIVE BIOPSY TECHNIQUES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Minimally Invasive Biopsy Techniques Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Minimally Invasive Biopsy Techniques Market Snippet by Product Offered
    • 2.1.2. Minimally Invasive Biopsy Techniques Market Snippet by Technique
    • 2.1.3. Minimally Invasive Biopsy Techniques Market Snippet by Circulating Biomaker
    • 2.1.4. Minimally Invasive Biopsy Techniques Market Snippet by Application
    • 2.1.5. Minimally Invasive Biopsy Techniques Market Snippet by End User
    • 2.1.6. Minimally Invasive Biopsy Techniques Market Snippet by Country
    • 2.1.7. Minimally Invasive Biopsy Techniques Market Snippet by Region
  • 2.2. Competitive Insights

3. Minimally Invasive Biopsy Techniques Key Market Trends

  • 3.1. Minimally Invasive Biopsy Techniques Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Minimally Invasive Biopsy Techniques Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Minimally Invasive Biopsy Techniques Market Opportunities
  • 3.4. Minimally Invasive Biopsy Techniques Market Future Trends

4. Minimally Invasive Biopsy Techniques Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Minimally Invasive Biopsy Techniques Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Minimally Invasive Biopsy Techniques Market Landscape

  • 6.1. Minimally Invasive Biopsy Techniques Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Minimally Invasive Biopsy Techniques Market - By Product Offered

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Offered, 2024 & 2032 (%)
    • 7.1.2. Tests
    • 7.1.3. Kits & Consumables
    • 7.1.4. Instruments

8. Minimally Invasive Biopsy Techniques Market - By Technique

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technique, 2024 & 2032 (%)
    • 8.1.2. Liquid Biopsy
    • 8.1.3. Optical Biopsy
    • 8.1.4. Brush Biopsy
    • 8.1.5. Pigmented Lesion Assays
    • 8.1.6. Others

9. Minimally Invasive Biopsy Techniques Market - By Circulating Biomaker

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Circulating Biomaker, 2024 & 2032 (%)
    • 9.1.2. Circulating Tumor Cells (CTCs)
    • 9.1.3. Cell Free DNA (cfDNA)
    • 9.1.4. Circulating Tumor DNA (ctDNA)
    • 9.1.5. Extracellular Vesicles
    • 9.1.6. Others

10. Minimally Invasive Biopsy Techniques Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Clinical
      • 10.1.2.1. Treatment Monitoring
      • 10.1.2.2. Prognosis & Recurrence Monitoring
      • 10.1.2.3. Treatment Selection
      • 10.1.2.4. Others
    • 10.1.3. Therapeutic
      • 10.1.3.1. Lung Cancer
      • 10.1.3.2. Breast Cancer
      • 10.1.3.3. Prostate Cancer
      • 10.1.3.4. Colorectal Cancer
      • 10.1.3.5. Others

11. Minimally Invasive Biopsy Techniques Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Hospitals & Clinics
    • 11.1.3. Academic & Research Institutions
    • 11.1.4. Ambulatory Care Centers

12. Minimally Invasive Biopsy Techniques Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Minimally Invasive Biopsy Techniques Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Minimally Invasive Biopsy Techniques Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Offered, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Circulating Biomaker, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Minimally Invasive Biopsy Techniques Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Becton, Dickinson and Company (BD)
    • 13.2.2. Danaher Corporation (Leica Biosystems)
    • 13.2.3. Hologic, Inc.
    • 13.2.4. Boston Scientific Corporation
    • 13.2.5. Medtronic plc
    • 13.2.6. Siemens Healthineers
    • 13.2.7. GE HealthCare
    • 13.2.8. Philips Healthcare
    • 13.2.9. Argon Medical Devices
    • 13.2.10. Cook Medical
    • 13.2.11. Fujifilm Holdings Corporation
    • 13.2.12. Olympus Corporation
    • 13.2.13. R. Bard (now part of BD)
    • 13.2.14. Biocept, Inc.
    • 13.2.15. Guardant Health
    • 13.2.16. Qiagen N.V.
    • 13.2.17. Exact Sciences Corporation
    • 13.2.18. Bio-Rad Laboratories
    • 13.2.19. Menarini Silicon Biosystems
    • 13.2.20. NeoGenomics Laboratories
    • 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us